Quantitative Nodal Burden as a Determinant Identifying Ampullary Adenocarcinoma Patients Benefiting From Adjuvant Chemotherapy

NCT06435767 · clinicaltrials.gov ↗

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Ampullary Adenoma
Chemotherapy Effect

Interventions

DRUG: Adjuvant chemotherapy

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences